Riskpilot← Back to searchSign inGet full accessProbioform AB
ABActiveOrg 5568663107Sunnemo GårdRetail sale of other food · NACE 4727Est. 20110 employees
Revenue 2024
SEK 219K
+1969% vs 2023
EBITDA margin
-10.7%
-2% vs 2023
Equity ratio
57.4%
Financial strength
Net profit 2024
SEK -24K
-2% vs 2023
| Revenue | SEK 219K | +1969% |
| EBITDA | SEK -23K | -2% |
| Net profit | SEK -24K | -2% |
| Total assets | SEK 49K | -30% |
| Equity | SEK 28K | -45% |
| Employees | 0 | — |
Legal name
Probioform AB
Org number
5568663107
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
4 oktober 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget ska bedriva handel med hälsoprodukter och hälsokost samt konsultation inom hälsokost samt därmed förenlig verksamhet.
Address
Sunnemo Gård
Email
info@probiform.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 11 | 219 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | −8 | −23 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 0 | 0 | −8 | −23 | −23 |
| Net financials | — | — | — | −0 | −0 |
| Profit before tax | 43 | 0 | −8 | −23 | −24 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 43 | 0 | −8 | −23 | −24 |
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 60 | 60 | 50 | 70 | 49 |
| Equity | 54 | 54 | 47 | 52 | 28 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 6 | 6 | 3 | 18 | 21 |
| Total debt | 6 | 6 | 3 | 18 | 21 |
EBITDA margin
-10.7%
This company
15.8%
Market median
-168% vs market
20192024
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20192024
Return on equity
-83.2%
This company
18.4%
Market median
-552% vs market
20192024
Net profit margin
-10.8%
This company
8.1%
Market median
-233% vs market
20192024
Asset turnover
4.43×
This company
1.12×
Market median
+296% vs market
20192024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20192024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
V.N.D. - Konsult AB
Probioform AB Board members of Probioform AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Magnus Arnesson | Board of Directors | 0 companies |
| Analisa Kathryn Kihlman | Deputy Board Member | 0 companies |
| Klas Johan Erle | Chairman | 0 companies |